We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $119M | 0.54% |
1,571,214
+26,617
| +2% | +$2.03M |
|
27
iShares Core US Aggregate Bond ETF
AGG
$137B
| $119M | 0.54% |
1,209,803
+166,465
| +16% | +$16.5M |
|
28
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $116M | 0.53% |
1,555,272
-101,568
| -6% | -$7.42M |
|
29
SPDR Gold Trust
GLD
$143B
| $108M | 0.49% |
605,639
+63,103
| +12% | +$11.6M |
|
30
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
| $107M | 0.49% |
1,796,246
-145,890
| -8% | -$8.69M |
|
|
SPYM
31
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $102M | 0.47% |
1,959,452
-202,628
| -9% | -$10M |
|
32
ExxonMobil
XOM
$657B
| $102M | 0.46% |
949,884
-7,487
| -0.8% | -$817K |
|
33
Alphabet (Google) Class C
GOOG
$4.35T
| $101M | 0.46% |
836,621
+11,346
| +1% | +$1.31M |
|
34
First Trust Capital Strength ETF
FTCS
$7.99B
| $101M | 0.46% |
1,347,620
+23,333
| +2% | +$1.71M |
|
35
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $94.5M | 0.43% |
1,086,986
+116,656
| +12% | +$9.2M |
|
36
Johnson & Johnson
JNJ
$631B
| $93.7M | 0.43% |
565,974
+10,471
| +2% | +$1.69M |
|
37
Vanguard Extended Market ETF
VXF
$31.8B
| $93M | 0.42% |
624,807
+49,506
| +9% | +$6.94M |
|
38
Procter & Gamble
PG
$340B
| $92.1M | 0.42% |
606,793
+24,757
| +4% | +$3.73M |
|
39
Vanguard High Dividend Yield ETF
VYM
$83.7B
| $91.2M | 0.42% |
859,547
-12,472
| -1% | -$1.31M |
|
40
JPMorgan Chase
JPM
$956B
| $90.8M | 0.41% |
624,173
-20,997
| -3% | -$2.89M |
|
41
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
| $87.8M | 0.4% |
1,863,280
+58,876
| +3% | +$2.66M |
|
42
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $87.2M | 0.4% |
1,739,008
-368,482
| -17% | -$18.5M |
|
43
Visa
V
$675B
| $82.5M | 0.38% |
347,580
+12,176
| +4% | +$2.79M |
|
44
Eli Lilly
LLY
$1.1T
| $81.3M | 0.37% |
173,375
+20,551
| +13% | +$8.62M |
|
|
45
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.9B
| $74.7M | 0.34% |
987,753
+428,810
| +77% | +$32.6M |
|
46
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $72.9M | 0.33% |
968,431
+25,326
| +3% | +$1.93M |
|
47
Meta Platforms (Facebook)
META
$1.52T
| $71.9M | 0.33% |
250,503
+20,601
| +9% | +$5.08M |
|
48
iShares Core S&P Small-Cap ETF
IJR
$112B
| $71.5M | 0.33% |
717,078
+3,878
| +0.5% | +$369K |
|
49
iShares Core MSCI EAFE ETF
IEFA
$195B
| $70.2M | 0.32% |
1,040,401
+6,760
| +0.7% | +$458K |
|
50
AbbVie
ABBV
$438B
| $68.6M | 0.31% |
509,035
-10,060
| -2% | -$1.48M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.